Mu Yuan

1.4k total citations
67 papers, 1.2k citations indexed

About

Mu Yuan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mu Yuan has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Mu Yuan's work include Synthesis and biological activity (7 papers), Analytical Chemistry and Chromatography (6 papers) and Receptor Mechanisms and Signaling (6 papers). Mu Yuan is often cited by papers focused on Synthesis and biological activity (7 papers), Analytical Chemistry and Chromatography (6 papers) and Receptor Mechanisms and Signaling (6 papers). Mu Yuan collaborates with scholars based in China, United States and Sweden. Mu Yuan's co-authors include Biyun Huang, Minsheng Chen, Cheng-Feng Luo, Zhu Liu, Hong Ji, Hong Zhou, Ying Wu, Biao Wu, Shun Mao and Xia Chen and has published in prestigious journals such as The Plant Cell, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Mu Yuan

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mu Yuan China	19	570	156	155	122	121	67	1.2k
Dahong Yao China	19	644 1.1×	181 1.2×	141 0.9×	143 1.2×	46 0.4×	58	1.2k
Yuepiao Cai China	25	827 1.5×	351 2.3×	139 0.9×	139 1.1×	129 1.1×	66	1.7k
Yingzhuan Zhan China	18	487 0.9×	66 0.4×	134 0.9×	97 0.8×	56 0.5×	39	1.0k
Yali Wang China	21	631 1.1×	92 0.6×	104 0.7×	187 1.5×	38 0.3×	77	1.3k
Ming Ji China	21	692 1.2×	252 1.6×	137 0.9×	316 2.6×	86 0.7×	73	1.4k
Defeng Xu China	22	648 1.1×	243 1.6×	185 1.2×	181 1.5×	62 0.5×	108	1.6k
Xiang Pu China	22	785 1.4×	203 1.3×	201 1.3×	90 0.7×	45 0.4×	67	1.5k
Huang Jinling China	17	528 0.9×	113 0.7×	155 1.0×	162 1.3×	63 0.5×	55	1.3k
Bingling Dai China	19	544 1.0×	73 0.5×	199 1.3×	128 1.0×	88 0.7×	60	972
Weiling Li China	25	1.0k 1.8×	106 0.7×	340 2.2×	179 1.5×	98 0.8×	76	2.0k

Countries citing papers authored by Mu Yuan

Since Specialization

Citations

This map shows the geographic impact of Mu Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu Yuan more than expected).

Fields of papers citing papers by Mu Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu Yuan. The network helps show where Mu Yuan may publish in the future.

Co-authorship network of co-authors of Mu Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Mu Yuan. A scholar is included among the top collaborators of Mu Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu Yuan. Mu Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Hao, Mu Yuan, Zhifei Xu, et al.. (2025). Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity. Advanced Science. 12(14). e2414923–e2414923. 2 indexed citations

Hu, Xueting, Chengxiu Pu, Luoquan Ao, et al.. (2025). Lactylation-driven METTL3 regulates wound healing by enhancing m6A/HNRNPA2B1/DNMT1 signaling in keratinocytes. Genes & Diseases. 13(3). 101787–101787.

Yuan, Mu, Xin Huang, Rui Liu, et al.. (2021). ACPT gene is inactivated in mammalian lineages that lack enamel or teeth. PeerJ. 9. e10219–e10219. 13 indexed citations

Zhang, Zepeng, Mu Yuan, Lei Shan, et al.. (2019). Divergent Evolution of TRC Genes in Mammalian Niche Adaptation. Frontiers in Immunology. 10. 871–871. 4 indexed citations

Chen, Hong, Xue Liang, Tao Sun, et al.. (2018). Synthesis and biological evaluation of estrone 3- O -ether derivatives containing the piperazine moiety. Steroids. 134. 101–109. 13 indexed citations

Chen, Hong, Tao Sun, Zhan Zhou, et al.. (2018). Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives. Bioorganic & Medicinal Chemistry Letters. 28(9). 1534–1539. 12 indexed citations

Huang, Junjun, et al.. (2018). Novel naftopidil derivatives containing methyl phenylacetate and their blocking effects on α1D/1A-adrenoreceptor subtypes. Bioorganic & Medicinal Chemistry Letters. 28(4). 547–551. 6 indexed citations

Xü, Wei, et al.. (2017). Crystal structures, absolute configurations and molecular docking studies of naftopidil enantiomers as α1D-adrenoceptor antagonists. Acta Pharmaceutica Sinica B. 7(4). 496–501. 6 indexed citations

Yuan, Mu, et al.. (2016). Progress in the research of superoxide dismutase. 25(6). 558. 2 indexed citations

10.

Huang, Junjun, Yi Cai, Zhu Liu, et al.. (2016). Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen/androgen induced rat benign prostatic hyperplasia model in vivo. European Journal of Pharmacology. 791. 473–481. 18 indexed citations

11.

Xü, Wei, et al.. (2016). Design, synthesis, crystal structure, biological evaluation and molecular docking studies of carbazole-arylpiperazine derivatives. Bioorganic & Medicinal Chemistry. 24(21). 5565–5572. 7 indexed citations

12.

Liu, Xiawen, Lijun Zhu, Biyun Huang, et al.. (2016). Poor and enantioselective bioavailability of naftopidil enantiomers is due to extensive and stereoselective metabolism in rat liver. Journal of Pharmaceutical and Biomedical Analysis. 132. 165–172. 4 indexed citations

13.

Bai, Mingzhu, Mu Yuan, Hong Liao, et al.. (2015). OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma. Oncology Reports. 33(4). 1745–1752. 32 indexed citations

14.

Xia, Longfei, Hong Zhou, Biao Wu, et al.. (2013). TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620. Tumor Biology. 34(5). 2573–2581. 49 indexed citations

15.

Luo, Cheng-Feng, Bin Cai, Ning Hou, et al.. (2012). UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes. Archives of Toxicology. 86(11). 1681–1690. 37 indexed citations

16.

Wu, Biao, et al.. (2012). Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620. Tumor Biology. 34(2). 837–846. 40 indexed citations

17.

Luo, Cheng-Feng, Mu Yuan, Minsheng Chen, et al.. (2011). Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. International Journal of Pharmaceutics. 410(1-2). 138–144. 128 indexed citations

18.

Luo, Cheng-Feng, Mu Yuan, Minsheng Chen, et al.. (2011). Determination of puerarin in rat plasma by rapid resolution liquid chromatography tandem mass spectrometry in positive ionization mode. Journal of Chromatography B. 879(19). 1497–1501. 22 indexed citations

19.

Yuan, Mu, et al.. (2009). Determination of puerarin in rat plasma by HPLC with fluorescence detection and its application to pharmacokinetic studies. Latin American Journal of Pharmacy. 2 indexed citations

20.

Luo, Cheng-Feng, Mu Yuan, Minsheng Chen, Shiming Liu, & Hong Ji. (2009). Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: Similar metabolic profiles in liver and intestine of rats. Journal of Chromatography B. 878(3-4). 363–370. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact